Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion type Assertion NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_head.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion evidence source_evidence_literature NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion SIO_000772 17653090 NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion wasDerivedFrom befree-2016 NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion wasGeneratedBy ECO_0000203 NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.